[The use of a beta 2-mimetic agent (clenbuterol) in equine pregnancy disorders and obstetrics].
A clinical study about the effects of a beta 2-mimetic agent (Clenbuterol) in mares with pregnancy disorders or disorders during the periparturient period (n = 34) is reported. In general, a single dose of 0.3 mg Clenbuterol given i.v. induces sufficient tocolysis. Subsequent doses or follow-up treatment depend upon individual development during dystocia, indication of treatment and clinical preparturient status (dorsoflexio uteri ante partum, abortus imminens, preparturient labor pains).
Bostedt
H
H
Ambulatorischen und Geburtshilflichen Veterinärklinik, Justus-Liebig-Universität Giessen.
D000818:Animals; D002976:Clenbuterol / Q000627:therapeutic use*; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D007744:Obstetric Labor Complications / Q000188:drug therapy / Q000662:veterinary*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000662:veterinary*; D011644:Puerperal Disorders / Q000188:drug therapy / Q000662:veterinary*
D004983:Ethanolamines; D002976:Clenbuterol
Zur Anwendung eines beta 2-Mimetikums (Clenbuterol) bei Graviditätsstörungen und in der Geburtshilfe des Pferdes.